Bottom line
RYJSX vs RYSBX: the short answer
RYJSX (Japan 2x Strategy Fund) and RYSBX (Strengthening Dollar 2x Strategy Fund) are both mutual funds.
RYJSX is cheaper at 1.54% vs 1.93% — a difference of $39 a year per $10,000 invested.
Over five years, RYSBX returned +6.4% a year vs −0.7% for RYJSX.
RYJSX has a front-end sales load of up to 4.75%; the other does not.
Updated Nov 19, 2026
RYJSX vs RYSBX side by side
| RYJSX | RYSBX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Guggenheim | Guggenheim |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 1.54% | 1.93% |
| Annual cost per $10k | $154 | $193 |
| 10-yr cost on $10k (prospectus) | $2,270 | $2,351 |
| Max front load | 4.75% | — |
| 12b-1 fee | 0.25% | 0.25% |
| 1-yr return | +43.6% | −14.1% |
| 5-yr return (annualized) | −0.7% | +6.4% |
| 10-yr return (annualized) | +9.1% | +1.9% |
| Best quarter | — | +17.3% |
| Worst quarter | — | −14.4% |
| Net assets (fund) | $3.8M | $2.3M |
| Number of holdings | 5 | 4 |
| Portfolio turnover | % | % |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
2 of RYJSX's top 5 holdings also appear in RYSBX's top 4.
| Holding | RYJSX | RYSBX |
|---|---|---|
| J.p. Morgan Securities Llc | 35.05% | 46.73% |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | 35.05% | 46.73% |
Source: SEC Form N-PORT
RYJSX top 10
- J.p. Morgan Securities Llc — 35.05%
- Merrill Lynch, Pierce, Fenner & Smith Incorporated — 35.05%
- Chicago Mercantile Exchange — 9.65%
- Chicago Mercantile Exchange — 4.06%
- Chicago Mercantile Exchange — -2.47%
RYSBX top 10
- J.p. Morgan Securities Llc — 46.73%
- Merrill Lynch, Pierce, Fenner & Smith Incorporated — 46.73%
- Ice Futures U.s. — 0.89%
- Goldman Sachs & Co. Llc — 0.36%
FAQ
What is the difference between RYJSX and RYSBX?
Which is cheaper, RYJSX or RYSBX?
Should I own both RYJSX and RYSBX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.